Group One Trading’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,347
Closed -$151K 8615
2025
Q2
$146K Buy
7,347
+171
+2% +$3.33K ﹤0.01% 4643
2025
Q1
$121K Buy
7,176
+6,815
+1,888% +$116K ﹤0.01% 4446
2024
Q4
$6.67K Buy
361
+315
+685% +$6.15K ﹤0.01% 6298
2024
Q3
$1K Sell
46
-54
-54% -$1.21K ﹤0.01% 6293
2024
Q2
$1.96K Sell
100
-1,699
-94% -$35.5K ﹤0.01% 6233
2024
Q1
$39K Sell
1,799
-847
-32% -$21K ﹤0.01% 4919
2023
Q4
$76.5K Buy
2,646
+2,524
+2,069% +$67.5K ﹤0.01% 4698
2023
Q3
$3.26K Sell
122
-5,226
-98% -$178K ﹤0.01% 6884
2023
Q2
$198K Buy
5,348
+2,659
+99% +$92.7K ﹤0.01% 3936
2023
Q1
$84K Buy
2,689
+1,550
+136% +$49.9K ﹤0.01% 4447
2022
Q4
$33.9K Buy
+1,139
New +$40.8K ﹤0.01% 5258
2022
Q3
Sell
-4,598
Closed -$231K 7726
2022
Q2
$251K Buy
4,598
+1,070
+30% +$58.8K ﹤0.01% 4076
2022
Q1
$220K Buy
+3,528
New +$232K ﹤0.01% 4701
2021
Q3
Sell
-13,826
Closed -$1.26M 8350
2021
Q2
$1.27M Buy
+13,826
New +$1.1M ﹤0.01% 3125
2021
Q1
Sell
-23,439
Closed -$2.42M 7701
2020
Q4
$1.22M Buy
23,439
+4,931
+27% +$206K ﹤0.01% 2483
2020
Q3
$741K Buy
+18,508
New +$579K ﹤0.01% 2479

Other funds holding FLGT

Group One Trading's FLGT Position: Q3 2025 in Review

Group One Trading sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 7,347 shares — an estimated $151K sold.

Group One Trading first reported a position in FLGT in Q3 2020 and held it in 16 quarters. The position peaked at $1.27M in Q2 2021. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Group One Trading reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 7,347 Fulgent Genetics shares in Q3 2025, an estimated $151K.
  • Group One Trading first reported a position in Fulgent Genetics in Q3 2020 and held it in 16 quarters.
  • Group One Trading's Fulgent Genetics position peaked at $1.27M in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.